Pacira BioSciences (PCRX)
Develops non-opioid pain and musculoskeletal treatments built on a liposome drug-delivery platform.
$24.87
vs last close+0.17 (+0.70%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
$0.76
Revenue estimate
$182.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26Apr '26Aug '26Nov '26
Reported$0.91$0.62$0.74$0.70$0.57$0.60$0.73Pending
Estimate$0.78$0.57$0.72$0.65$0.85$0.61$0.65$0.76
Surprise+16.7%+8.8%+2.8%+7.7%−32.9%−1.6%+13.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26Apr '26Aug '26Nov '26
Reported$187.3M$168.9M$181.1M$179.5M$196.9M$177.4M$192.4MPending
Estimate$185.4M$187.5M$182.4M$201.9M$200.3M$171.8M$191.1M$182.2M
Surprise+1.0%−9.9%−0.7%−11.1%−1.7%+3.2%+0.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.97 | — | — |
| Sep 2027 | $0.86 | — | — |
| Jun 2027 | $0.78 | — | — |
| Mar 2027 | $0.76 | — | — |
| Dec 2026 | $0.83 | — | — |
| Nov 2026 | $0.76 | — | — |
| Aug 2026 | $0.65 | $0.73 | +13.0% |
| Apr 2026 | $0.61 | $0.60 | −1.6% |
| Feb 2026 | $0.85 | $0.57 | −32.9% |
| Nov 2025 | $0.65 | $0.70 | +7.7% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.97 | — | — | $221.0M | — | — | — |
| Sep 2027 | $0.86 | — | — | $192.8M | — | — | — |
| Jun 2027 | $0.78 | — | — | $191.8M | — | — | — |
| Mar 2027 | $0.76 | — | — | $189.0M | — | — | — |
| Dec 2026 | $0.83 | — | — | $201.8M | — | — | — |
| Nov 5, 2026 | $0.76 | — | — | $182.2M | — | — | — |
| Aug 4, 2026 | $0.65 | $0.73 | +13.0% | $191.1M | $192.4M | +0.7% | −10.0% |
| Apr 30, 2026 | $0.61 | $0.60 | −1.6% | $171.8M | $177.4M | +3.2% | −4.1% |
| Feb 26, 2026 | $0.85 | $0.57 | −32.9% | $200.3M | $196.9M | −1.7% | −3.0% |
| Nov 6, 2025 | $0.65 | $0.70 | +7.7% | $201.9M | $179.5M | −11.1% | +4.5% |
| Aug 5, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Jul 30, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 3, 2021 | |||||||
| May 4, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 20, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 2, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Nov 1, 2018 | |||||||
| Aug 2, 2018 | |||||||
| May 3, 2018 | |||||||
| Feb 28, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 4, 2017 | |||||||
| Mar 1, 2017 | |||||||
| Nov 2, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 2, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Oct 27, 2015 | |||||||
| Jul 30, 2015 |